Azacytidine enhances sensitivity response to Imatinib In BCR/ABL positive CML cell line
Purpose: Azacytidine (5-Aza) is a chemotherapeutic drug used for DNA-de-methylation resulting in re-expression of silenced tumor suppressor genes (TSG). Epigenetic silencing of TSG such as involved in the development and progression of cancers. Re-expression of SHP1 is inversely propo...
Saved in:
Main Authors: | Wan Rohani, Wan Taib, Hamid Ali Nagi, Al-Jamal, Muhammad Farid, Johan |
---|---|
Format: | Article |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://eprints.unisza.edu.my/5728/1/FH02-ICODE-18-12779.pdf http://eprints.unisza.edu.my/5728/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Proliferative Effects of Dendrophthoe pentandra Methanol Extract on BCR/ABL-Positive and Imatinib-Resistant Leukemia Cell Lines
by: Hamid Ali Nagi, Al-Jamal, et al.
Published: (2016) -
Detection of BCR-ABL T315i mutation in imatinib resistant chronic myeloid leukemia patients
by: Mardziah M,, et al.
Published: (2019) -
Aleukemic bcr-abl positive granulocytic sarcoma
by: Kuan, Jew-Win, et al.
Published: (2009) -
Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah, et al.
Published: (2012) -
Imatinib resistance and blast transformation of chronic myeloid leukemia associated with a novel tri-nucleotide insertion mutation of BCR-ABL kinase domain at position K294
by: Nadarajan, V.S., et al.
Published: (2012)